Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.48
2.82
NAV
₹36.89
₹349.81
Fund Started
20 Jun 2019
01 Aug 2005
Fund Size
₹900.87 Cr
₹1143.58 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year
10.63%
9.98%
3 Year
23.31%
25.97%
5 Year
12.61%
13.92%
Equity
98.61%
95.25%
Cash
1.39%
4.74%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.17% |
Apollo Hospitals Enterprise Ltd. | 7.20% |
Torrent Pharmaceuticals Ltd. | 4.76% |
JB Chemicals & Pharmaceuticals Ltd. | 4.71% |
Aurobindo Pharma Ltd. | 4.49% |
Ajanta Pharma Ltd. | 4.05% |
Lupin Ltd. | 4.00% |
Mankind Pharma Ltd. | 3.88% |
Fortis Healthcare Ltd. | 3.87% |
Abbott India Ltd. | 3.65% |
Sun Pharmaceutical Industries Ltd. | 9.49% |
Ajanta Pharma Ltd. | 5.84% |
Lupin Ltd. | 4.23% |
Apollo Hospitals Enterprise Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.45% |
Glenmark Pharmaceuticals Ltd. | 3.35% |
Dr. Reddy's Laboratories Ltd. | 3.35% |
Gland Pharma Ltd. | 3.30% |
Fortis Healthcare Ltd. | 3.23% |
Alkem Laboratories Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
20 Jun 2019
01 Aug 2005
